Beleaguered drugmaker Wockhardt has a new management team in place to implement a...
The Reliance-Anil Dhirubhai Ambani Group has picked up a 15 per cent stake for Rs 225...
Major Indian drug companies such as Ranbaxy Laboratories, Lupin, Dr Reddy's...
Major drug discovery outsourcing deals have almost dried up in the past 18 months for...
An increase in the number of outsourcing deals between domestic drug companies and...
Indian pharmaceutical companies may have spread their wings far and wide, but they have...
Three Indian companies are among the six shortlised to bid for the privatisation of the...
Last week, scientists working with the Institute of Genomics and Integrative Biology...
The share prices of power transmission and distribution company Areva T&D rose 2.8 per...
European wind turbine makers interested; deal could be $1 billion. The company aims to...
India emerging as a big global destination for contract manufacturing, unlike R&D...
The central government's decision to continue controlling supply of the swine flu drug,...
Bangalore-based Stempeutics Research received clearance from the Drug Controller...
In another development, leading Japanese drug maker Takeda Pharmaceutical sued...
Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex...
In what could be one of the largest outsourcing deals in the Indian telecom space,...
The world's fifth largest wind turbine maker, Suzlon Energy, which has been grappling...
The company is likely to increase buy-back offer from Rs 351 to Rs 425-450. The open...
GSK India, which has a turnover of Rs 1,751 crore (Rs 17.51 billion) and launched a...
Mukesh Ambani's privately held biotech research company, Reliance Life Sciences, will...